Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Tech Cabo Verde.
Press releases published on August 7, 2025
Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
GlobeNewswire
·
August 7, 2025
Company Announcement COPENHAGEN, Denmark; August 7, 2025 Epcoritamab in combination with rituximab and lenalidomide (R2) demonstrated statistically significant improvement in Overall Response Rate (ORR; 95.7%, p < 0.0001) and Progression-Free Survival (HR …
Meteor Profit: Why Traders Are Backing This Meteor Profit AI-Based Trading App for Security and ROI – Read Canada Trading App Report!
GlobeNewswire
·
August 7, 2025
New York City, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Amid growing demand for intuitive, secure trading solutions, Meteor Profit has emerged as a rising contender among Canadian investors seeking a smarter approach to online trading. The AI-driven platform, …
Alkeus Pharmaceuticals Announces Presentation of Positive Interim TEASE-3 Study Data in Early-Stage Stargardt Disease Patients Treated with Oral Gildeuretinol
GlobeNewswire
·
August 7, 2025
Gildeuretinol acetate demonstrated less loss in ellipsoid zone (EZ) area compared to historical sibling controls. Early-stage Stargardt disease patients treated with gildeuretinol for two to seven years exhibited relatively stable disease over the course …
Loka Joins AWS Generative AI Innovation Center to Accelerate Enterprise-Scale Innovation
GlobeNewswire
·
August 7, 2025
PALO ALTO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Loka, a leading software consultancy and AWS Premier Tier Services Partner, today announced it has joined the AWS Generative AI Innovation Center (GenAIIC) Partner Innovation Alliance. Loka is one of 19 …
Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets primary endpoint in CONVOKE study for negative symptoms in schizophrenia
GlobeNewswire
·
August 7, 2025
CT-155 showed a reduction in experiential negative symptoms as an adjunct to standard of care antipsychotic therapy from baseline to week 16, as measured by CAINS-MAP. CT-155 is an investigational prescription digital therapeutic being evaluated to target …
True Tickets Accelerates U.S. Momentum with New Venue Partnerships and PatronSafe Innovation
GlobeNewswire
·
August 7, 2025
Boston, Aug. 07, 2025 (GLOBE NEWSWIRE) -- True Tickets, the secure digital ticket delivery service redefining audience relationships for arts and cultural institutions, is building strong summer momentum across the United States with major new venue …
Summit Equity Partners Ltd Launches Flagship AegisX System, Pioneering Independent Financial Education and AI-Driven Quantitative Investment Solutions
GlobeNewswire
·
August 7, 2025
Denver, CO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Summit Equity Partners Ltd, a leading U.S.-based independent financial education and research institution, proudly announces the launch of AegisX 4.0, its cutting-edge, AI-powered quantitative wealth advisory …
AvidXchange and Ministry Brands Announce Exclusive Partnership
GlobeNewswire
·
August 7, 2025
CHARLOTTE, N.C. and KNOXVILLE, Tenn., Aug. 07, 2025 (GLOBE NEWSWIRE) -- AvidXchange, Inc. a leading provider in accounts payable (AP) automation, offering intelligent AP software and payment solutions for mid-market businesses and their suppliers, today …
ESET PROTECT Elite is a Security Winner of the 2025 CRN Tech Innovators Awards
GlobeNewswire
·
August 7, 2025
SAN DIEGO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, announced today that CRN®, a brand of The Channel Company, has named ESET PROTECT Elite a winner in the 2025 CRN Tech Innovator Awards for the Endpoint Protection/ …
Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years
GlobeNewswire
·
August 7, 2025
RA'ANANA, Israel, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced that it has …
Drone-as-a-Service Market Revenue Estimated to Reach $27 Billion by 2033 with Robust Growth Expected in Coming Years
GlobeNewswire
·
August 7, 2025
PALM BEACH, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to a report from Verified Market Reports: “The Drone-as-a-Service Market Revenue was valued at USD 6.3 Billion in 2024 and is estimated to reach USD 27.3 Billion …
Rheumatologists Eagerly Anticipate Pipeline Advancements in Idiopathic Inflammatory Myopathies to Address Deep Unmet Need, According to Spherix Global Insights
GlobeNewswire
·
August 7, 2025
EXTON, PA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Despite recent increased use of intravenous immunoglobulin (IVIg) and biologics, the majority of patients with idiopathic inflammatory myopathies (IIM)—including classic dermatomyositis (DM), polymyositis (PM), …
EdgeMode Signs Non-Binding Term Sheet for $4 Million Convertible Note to Support Infrastructure Development and Growth Strategy
GlobeNewswire
·
August 7, 2025
FORT LAUDERDALE, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- EdgeMode, Inc. (OTC: EDGM), a next-generation provider of high-performance, sustainable computing infrastructure, today announced it has signed a non-binding term sheet for a $4 million convertible …
Palisade Bio Reports 100% Clinical Response in Phase 1b Ulcerative Colitis Cohort with Novel PDE4 Inhibitor, PALI-2108
GlobeNewswire
·
August 7, 2025
PALI-2108 demonstrated to be safe and well tolerated with no serious adverse events (SAEs) Extended half-life and local bioactivation support convenient once-daily dosing in ulcerative colitis (UC) and fibrostenotic Crohn’s disease (FSCD) Colon tissue drug …
Wrap Technologies, Inc. Plans to Hold a Conference Call to Discuss Second Quarter 2025 Financial Results on Thursday, August 14, 2025 at 4:30 p.m. ET
GlobeNewswire
·
August 7, 2025
MIAMI, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc, (NASDAQ: WRAP) (“Wrap” or, the “Company”), a global leader in innovative public safety technologies and non-lethal tools, today announces it plans to hold a conference call on Thursday, …
Geotab completa 25 anos como referência global em telemetria e inteligência de dados
GlobeNewswire
·
August 7, 2025
SÃO PAULO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Imagem: Geotab/Divulgação A Geotab, líder global em soluções de transporte conectado, completa 25 anos de atuação global, destacando sua trajetória de crescimento e inovação baseada em inteligência de dados. Com …
AppSignal Provides Powerful Application Performance Monitoring With OpenTelemetry for Resource-Constrained Development Teams
GlobeNewswire
·
August 7, 2025
AMSTERDAM and AUSTIN, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) -- AppSignal today announced the expansion of its application performance monitoring (APM) product suite to make OpenTelemetry (OTel) fully accessible for small and midsize businesses (SMBs). …
Samba TV Report Finds Advertiser Confidence is Up with 68% of Top 100 Brands Accelerating TV Advertising in First Half of 2025
GlobeNewswire
·
August 7, 2025
Starbucks doubled down on TV with 88% increase, while Dunkin pulled back -61%; T-Mobile led the Telco sector with TV investment up 34%, while Verizon shifted away from TV -37% SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Samba TV, the global leader in …
Employers pull back on pay increases despite rising inflation, Payscale Salary Budget Survey Finds
GlobeNewswire
·
August 7, 2025
After years of strong wage growth driven by a competitive labor market, U.S. employers are pulling back and planning for a 3.5% salary budget increase in 2026, down 0.1% from 2025, suggesting salary budgets are settling into a more sustainable pace after …
NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia
GlobeNewswire
·
August 7, 2025
CALABASAS, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a multi–Phase 2 clinical-stage biotechnology company focused on breakthrough therapies for central nervous system (CNS) malignancies, today announced the …